Dana-Farber Research News 04.15.2026 - Takeaways - MDSpire

Dana-Farber Research News 04.15.2026

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from March 16 - 31.

  • April 15, 2026

  • 22 min

Share

  • 1

    Dana-Farber's Research News highlights recent studies by faculty, focusing on cancer research published from March 16 to 31, 2026.

  • 2

    A study on pineoblastoma reveals a tumor-associated photoreceptor signature that links various central nervous system malignancies.

  • 3

    Monetary transfer interventions are being tested in clinical cancer research to improve health outcomes by addressing economic conditions.

  • 4

    Research indicates that older patients with brain metastases have a median survival of 3.42 months, with disparities in treatment approaches.

  • 5

    Thymic health may be a critical factor in predicting immunotherapy outcomes, emphasizing the need for better biomarkers in cancer treatment.

Original Source(s)

Dana-Farber Research News 04.15.2026

  • April 15, 2026

Related Content

Molecular tumor board availability and organization in sarcoma referral centers in Italy: are we on the right track?

Correlation between nerve conduction velocity abnormality patterns and clinical severity grading in chemotherapy-induced peripheral neuropathy: a retrospective cohort study

Comprehensive Cancer Care for the Doral Community

Baptist Health Cancer Care is now serving patients in Doral with a comprehensive, community-based approach to oncology care designed to make treatment more convenient and accessible for both patients and referring physicians.

  • by

  • June 2, 2026

  • 2 min